William Tisdall, MD
Interventional Pain Medicine · San Antonio, TXNPI 1124153754
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (42.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 94.8% of it on its own, with 19 other manufacturers making up the rest.
Across 263 payments — averaging $115.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$29K
- Abbott$447
- Medtronic$346
- Si-bone, Inc.$202
- Daiichi Sankyo Inc.$124
- Nevro Corp.$95
- plus $369 from 14 others
What the payments were for
- Consulting fees$13,07543%
- Speaking & faculty fees$10,85036%
- Travel & lodging$1,3344%
- Food & beverage$5,19017%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 192 | $28,866 |
| Abbott | 16 | $447 |
| Medtronic(2 entities) | 15 | $346 |
| Si-bone, Inc. | 4 | $202 |
| Daiichi Sankyo Inc. | 10 | $124 |
| Nevro Corp. | 5 | $95 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $85 |
| Nalu Medical, Inc. | 3 | $51 |
| Collegium Pharmaceutical, Inc. | 2 | $50 |
| GRT US Holding, Inc. | 1 | $26 |
| Orthogenrx Inc. | 1 | $20 |
| Globus Medical | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Biotronik NRO, Inc. | 1 | $18 |
| Stryker | 1 | $18 |
| Forte Bio-pharma LLC | 1 | $15 |
| Novartis | 1 | $14 |
| AstraZeneca | 1 | $12 |
| Scilex Pharmaceuticals Inc. | 1 | $12 |
| Biodelivery Sciences International, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$5,417
- WaveWriter Alpha Prime 16$5,238
- WAVEWRITER ALPHA$4,250
- GENERAL PAIN MANAGEMENT$2,608
- GENERAL - THERAPIES$1,738
- Neuromodulation Dspsbls and Accs$142
- iFuse Implant$125
- Axium INS DRG IPG$104
How this compares
$30,449 in reported general payments places this provider in the 85th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 4,077 | $123,822 |
| PercocetOxycodone Hcl/Acetaminophen | 11 | $35,691 |
| Naloxone Hcl | 183 | $11,776 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 271 | $6,767 |
| Oxycodone Hcl | 322 | $5,872 |
| Morphine Sulfate ErMorphine Sulfate | 160 | $4,943 |
| Hydromorphone Hcl | 155 | $2,094 |
| Lidocaine | 12 | $1,372 |
| Pregabalin | 27 | $938 |
| Morphine Sulfate | 42 | $922 |
| Gabapentin | 68 | $880 |
| Methadone Hcl | 34 | $513 |
| Cephalexin | 39 | $291 |
| Tizanidine Hcl | 26 | $269 |
| Clindamycin Hcl | 13 | $96 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in San Antonio
- Sarah TrampotaSan Antonio$37K
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.1M
- Chad StephensSouthlake$1M
- Ankur KhoslaShenandoah$277K
- Brian RichDecatur$245K
- Brian BruelHouston$219K
- Bolkar SahinlerLubbock$188K
- Timothy RatinoFort Worth$139K
- Genaro GutierrezAustin$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.